Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10023


Purpose:

Recent research on the effects of nicotine on the brain and behavior presents an opportunity to advance medication development. The purpose of this study is to develop a laboratory model for early-stage testing of new and existing treatments for nicotine addiction. Specifically, we will develop a laboratory model of smoking relapse in nicotine dependent volunteers.


Study summary:

Tobacco use is the leading preventable cause of death in the United States. Recent research on the effects of nicotine on the brain and behavior presents an opportunity to advance medication development. The goal of this study is to develop a laboratory model for early-stage testing of new and existing compounds for the treatment of tobacco and nicotine addiction. In addition, the objective of this study is to develop a laboratory model of relapse induced by cigarette exposure that would reproduce the psychological and physiological processes that are involved when abstinent individuals progress from initial cigarette smoking (lapse) to a pre-abstinence level of use (relapse). Such a model may be used to study the mechanisms of relapse and to screen medications that might be effective in preventing relapse in treatment seekers. This study will consist of two phases. Each phase will consist of a 5-day inpatient stay. During the first portion of inpatient stay, participants will not be permitted to smoke. During the second portion of inpatient stay, smoking reinstatement will be modeled, as participant will have opportunity to smoke, following the exposure to tobacco-related or control cues. A variety of behavioral, subjective, physiological, and performance measures will be assessed throughout the study.


Criteria:

Inclusion Criteria: - DSM-IV diagnosis of nicotine dependence with psychological dependence - Smokes at least 15 cigarettes per day for the three months prior to enrollment - Currently not seeking treatment for nicotine dependence - Medically healthy, on the basis of physical examination and medical history, vital signs, EKG, and laboratory tests - Females must use an effective method of contraception for the duration of the study Exclusion Criteria: - DSM-IV diagnosis of abuse or dependence on alcohol or drugs other than nicotine - Current Axis I diagnosis or current treatment with psychotropic medications within the 3 months prior to enrollment - History of schizophrenia or other psychotic disorders, bipolar disorder, or anxiety disorders - Currently seeking treatment for nicotine disorders - On parole or probation - History of seizures or head trauma with loss of consciousness, brain contusion, or fracture - History of significant recent violent behavior - Blood pressure greater than 150/90 - History of eating disorders - Pregnant


NCT ID:

NCT00136838


Primary Contact:

Principal Investigator
Adam Bisaga, M.D.
New York State Psychiatric Institute


Backup Contact:

N/A


Location Contact:

New York, New York 10023
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 12, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.